The affirmation is based on several positive and negative factors, including the health system’s leading market position, recovering volume trends, weak cash levels, high leverage and moderate capital needs. Moody’s also acknowledged that MaineGeneral’s profitability will remain highly reliant on 340B drug discount savings and its contract pharmacy business, which has come under regulatory scrutiny.
The outlook is stable, reflecting Moody’s expectation that MaineGeneral will sustain its operating performance and liquidity levels.
More articles on healthcare finance:
Hospital uncompensated care surges 14% to $1.1B in Wisconsin
Mayo Clinic gets $10M donation to support 5 initiatives
12 recent hospital, health system outlook and credit rating actions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
